as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹123.08
Change
+2.13 (1.76%)
Open
₹123.29
Prev. Close
₹120.95
Day High
₹125.71
Day Low
₹119.71
Volume Analysis
Traded
800,940
Delivered
320,096
Delivery %
39.97%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong return on equity (29.1%)
Weaknesses (0)
No signal for this stock
Opportunities (2)
- •Strong 3-year EPS growth (41.8%)
- •Strong 3-year revenue growth (25.7%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹131.95 | ₹128.83 | ₹125.95 | ₹122.83 | ₹119.95 | ₹116.83 | ₹113.95 |
| Fibonacci | ₹128.83 | ₹126.54 | ₹125.12 | ₹122.83 | ₹120.54 | ₹119.12 | ₹116.83 |
| Camarilla | ₹124.73 | ₹124.18 | ₹123.63 | ₹122.83 | ₹122.53 | ₹121.98 | ₹121.43 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+1.39%
1 Week
+0.14%
1 Month
-20.74%
3 Months
+3.26%
6 Months
+17.96%
1 Year
-8.65%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
DuPont ROE Breakdown
41.46%
Net margin 5.24% × asset turnover 2.21x × equity multiplier 3.58x
Company Overview
Sector
Chemicals
Market Cap
₹758 Cr
P/E (TTM)
29.6
ROE
29.1%
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 18 Nov 2026. Not investment advice.
TopFund Analysis
Advance Agrolife Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 54/100. The strongest factor is Growth (100/100), while Cash Flow (12/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (29.1%). Strong 3-year EPS growth (41.8%).
TopFund Score — Fundamentals Quality
54/100 — AverageData confidence: 76/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Newspaper Publication - Unaudited Financial Results for the quarter and half year ended September 30, 2026
Investor Presentation pertaining to Un-audited financial Results for the Quarter and half year ended 30.09.2026
H1 FY27 PAT rose 38.4% to ₹343.4 million; revenue increased 62% to ₹6,175.6 million.
Board approved Q2 FY27 results and obtained registration for 4 MW captive solar project in Bikaner.
Board approved Q2/H1 FY27 results and secured 4 MW captive solar project registration in Rajasthan.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2024 (S) | Sep 2024 (S) | Dec 2024 (S) | Mar 2025 (S) | Jun 2025 (S) | Sep 2025 (S) | Dec 2025 (S) | Mar 2026 (S) | Jun 2026 (S) | Sep 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 132 | 167 | 113 | 90 | 169 | 213 | 133 | 124 | 330 | 287 |
| Expenses + | 119 | 144 | 107 | 84 | 152 | 187 | 125 | 110 | 295 | 265 |
| Operating Profit | 12 | 23 | 6 | 6 | 17 | 26 | 7 | 13 | 35 | 22 |
| OPM % | 9.0% | 14.0% | 6.0% | 7.0% | 10.0% | 12.0% | 6.0% | 11.0% | 11.0% | 8.0% |
| Other Income + | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 |
| Interest | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 3 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 10 | 20 | 3 | 2 | 13 | 21 | 4 | 10 | 30 | 16 |
| Tax % | 28.0% | 29.0% | 17.0% | 28.0% | 29.0% | 25.0% | 30.0% | 25.0% | 25.0% | 26.0% |
| Net Profit + | 7 | 14 | 3 | 1 | 9 | 16 | 3 | 7 | 23 | 12 |
| EPS in Rs | 2 | 3 | 1 | 0 | 2 | 4 | 0 | 1 | 4 | 2 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | — | — | — | — | 28 | 27 | 17 | 38 | 96 | 35 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales + | 204 | 250 | 395 | 451 | 496 |
| Expenses + | 188 | 235 | 370 | 412 | 447 |
| Operating Profit | 16 | 15 | 25 | 40 | 49 |
| OPM % | 8.0% | 6.0% | 6.0% | 9.0% | 10.0% |
| Other Income + | 0 | 2 | 0 | 1 | 1 |
| Interest | 2 | 2 | 3 | 4 | 7 |
| Depreciation | 2 | 2 | 2 | 3 | 8 |
| Profit before tax | 12 | 12 | 20 | 33 | 35 |
| Tax % | 27.0% | 28.0% | 26.0% | 26.0% | 27.0% |
| Net Profit + | 9 | 9 | 15 | 25 | 26 |
| EPS in Rs | 2 | 2 | 3 | 6 | 6 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Sales growth | — | 22 | 58 | — | 10 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Reserves | 22 | 31 | 46 | 71 | 56 |
| Borrowings + | 16 | 21 | 25 | 45 | 80 |
| Other Liabilities + | 43 | 62 | 104 | 139 | 170 |
| Total Liabilities | 86 | 119 | 179 | 260 | 351 |
| Fixed Assets + | 16 | 17 | 23 | 40 | 66 |
| CWIP | 0 | 0 | 0 | 9 | 11 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 70 | 102 | 157 | 210 | 275 |
| Total Assets | 86 | 119 | 179 | 260 | 351 |
| Equity Capital | 4 | 4 | 4 | 4 | 45 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | 8 | 0 | 6 | 15 | 6 |
| Cash from Investing Activity + | -6 | -3 | -8 | -31 | -34 |
| Cash from Financing Activity + | -2 | 4 | 1 | 17 | 28 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 2 | -3 | -2 | -15 | -28 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 50 | 30 | 38 | 55 | 27 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|
| Public | 23.04% | 25.61% | 24.21% | 23.95% |
| Promoters | 69.89% | 69.89% | 69.89% | 69.89% |
| Government | 0.6% | 0.0% | 0.0% | 0.0% |
| FII | 4.42% | 2.58% | 3.82% | 4.19% |
| DII | 2.03% | 1.92% | 2.08% | 1.97% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Advance Agrolife Limited (this stock) | 758 | 29.6 | — | 29.1% |
| Transpek Industry Ltd | 760 | 16.2 | 0.95 | 6.14% |
| Sadhana Nitrochem Limited | 764 | — | 1.64 | -23.5% |
| Gem Aromatics Limited | 743 | 628.0 | 1.71 | 0.39% |
| Jayant Agro Organics Ltd | 718 | 10.9 | 1.1 | 8.53% |
| Amal Ltd. | 800 | 26.8 | 5.68 | 20.4% |
| Sudarshan Pharma Ind Ltd | 800 | 27.6 | 4.09 | 16.3% |
Which Mutual Funds Hold Advance Agrolife Limited?
Frequently Asked Questions about Advance Agrolife Limited
Advance Agrolife Limited (ADVANCE) closed at ₹123.08 on NSE on 19 November 2026, up 2.13 (1.76%) from the previous close.
Advance Agrolife Limited trades on the NSE (National Stock Exchange of India) under the symbol ADVANCE.
Advance Agrolife Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 29.6.
Advance Agrolife Limited has a dividend yield of 0.0%.
Advance Agrolife Limited's 52-week high is ₹165.0 and its 52-week low is ₹84.1.
Advance Agrolife Limited has a market capitalisation of ₹758 crore.
Advance Agrolife Limited has a TopFund Quality Score of 54/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Advance Agrolife Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.